Letter to the Editor: Interferon Is Not an Optimal Treatment for Chronic Hepatitis Delta but Needs "Fair Treatment" by Us
- PMID: 32767786
- DOI: 10.1002/hep.31501
Letter to the Editor: Interferon Is Not an Optimal Treatment for Chronic Hepatitis Delta but Needs "Fair Treatment" by Us
Comment in
-
REPLY.Hepatology. 2021 Aug;74(2):1127-1128. doi: 10.1002/hep.31508. Epub 2021 May 21. Hepatology. 2021. PMID: 32767793 No abstract available.
Comment on
-
Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes.Hepatology. 2020 Oct;72(4):1177-1190. doi: 10.1002/hep.31214. Epub 2020 Sep 24. Hepatology. 2020. PMID: 32145073
References
-
- Kamal H, Westman G, Falconer K, Duberg A‐S, Weiland O, Haverinen S, et al. Long‐term study of hepatitis D infection at secondary care centers: the impact of viremia on liver‐related outcomes. Hepatology 2020;72:1177‐1190.
-
- Yurdaydin C, Keskin O, Kalkan Ç, Karakaya F, Çalişkan A, Kabaçam G, et al. Interferon treatment duration in patients with chronic delta hepatitis and its effect on the natural course of the disease. J Infect Dis 2018;217:1184‐1192.
-
- Wranke A, Serrano BC, Heidrich B, Kirschner J, Bremer B, Lehmann P, et al. Antiviral treatment and liver‐related complications in hepatitis delta. Hepatology 2017;65:414‐425.
-
- Yurdaydin C. Treatment of chronic delta hepatitis. Sem Liver Dis 2012;32:237‐244.
-
- Heidrich B, Yurdaydın C, Kabaçam G, Ratsch BA, Zachou K, Bremer B, et al. Late HDV RNA relapse after peginterferon α‐based therapy of chronic hepatitis delta. Hepatology 2014;60:87‐97.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
